Clinical Trials Browser

Neoplasm Metastasis, Endometrial Neoplasms

NCT01629615 2020-10-28

A Trial of BKM120 (a PI3K Inhibitor) in Patients With Triple Negative Metastatic Breast Cancer

Phase 2 Completed

50 enrolled 10 charts

Breast

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT01737450 2019-06-24

PIK-ORL

Phase 2 Completed

58 enrolled

Head & Neck

Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence, Disease Progression

NCT01741753 2019-02-05

BKM120+Abiraterone Acetate for Metastatic CRPC

Phase 1 Terminated

4 enrolled

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT01790932 2019-01-23

BKM120 For Triple Negative Breast Cancer

Phase 2 Completed

50 enrolled 8 charts

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01385293 2017-05-19

BKM120 in Metastatic Castration-resistant Prostate Cancer

Phase 2 Terminated

30 enrolled 11 charts

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT02452294 2017-05-03

BUMPER

Phase 2 Unknown

22 enrolled

Dermatologic

Melanoma, Neoplasm Metastasis

NCT01571024 2017-04-26

BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer

Phase 1 Completed

17 enrolled

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms, Colorectal Neoplasms

NCT02035124 2016-02-11

Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel

Phase 2 Withdrawn

Tumor-Agnostic

Neoplasm Metastasis

Clinical Trials

ENDOPIK

A Trial of BKM120 (a PI3K Inhibitor) in Patients With Triple Negative Metastatic Breast Cancer

PIK-ORL

BKM120+Abiraterone Acetate for Metastatic CRPC

BKM120 For Triple Negative Breast Cancer

BKM120 in Metastatic Castration-resistant Prostate Cancer

BUMPER

BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer

Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel